ET

Summary

Initiate a staged long position in ET (Energy Transfer LP) with a Buy rating. Entry strategy: deploy a half position (~50% of intended allocation) at current levels near $21.00 to ensure participation if the breakout extends, and hold the remaining dry powder for a pullback into the $20.24–$20.63 support zone (Bollinger middle band / 10 EMA). Position sizing: full intended allocation only after either a confirmed breakout above $21.13 or a pullback into support. Risk levels: hard stop below the 50 SMA at $19.30 (roughly 1.5–2x ATR below the medium-term trend), representing ~8% downside. Upside target: analyst target of $24.39 (~16% upside), with partial profit-taking near the upper Bollinger Band if the stock re-extends. Time horizon: 5–20 trading days for the tactical trade, with the dividend (6.46% yield) supporting a longer hold through any pullback. Monitor the September rate decision/Treasury yields, natural gas prices, Oracle Project Jupiter timeline, and TanQuid M&A integration.

The case

The balance of evidence supports a directional long, with conviction tempered by short-term technical extension. Three of four analyst reports are constructive, and our analysis strengthened rather than weakened the bull case.

Bull case (well-supported): Q2 net income of $2.09B with zero unusual items, operating cash flow of $4.27B, and a positive FCF inflection to $2.71B (vs. negative $225M in Q4 2025) show genuine, operating-driven acceleration. Management raised 2026 EBITDA guidance, meaning growth is happening today, not contingent on a single 2027 catalyst. Valuation is attractive at ~12x forward earnings with a PEG of 0.67 and a 6.46% yield. The most alarming bear claim — that the $70B debt load is a solvency risk — is effectively neutralized by the interest coverage math: ~4.6x coverage and ~3.4x EBITDA leverage are within midstream norms and improving, and the TanQuid debt is secured by acquired assets. The bear case also overstated the Oracle pipeline delay as a "core thesis break" when it is one project affecting one campus, while Project Jupiter remains on schedule. Insider buying (~$260K) and institutional accumulation reinforce the constructive read.

Bear case (partially valid): The stock is genuinely extended short-term — RSI ~68.9, price hugging the upper Bollinger Band at $21.13, and 16.9% above the 200 SMA. The $70B debt load with $934M/quarter rising interest expense is a legitimate concern, and the current ratio of 1.16 is a thin cushion. The unanimous 13:0 sentiment is a mild contrarian caution. However, these argue for entry discipline, not avoidance.

Cross-ticker calibration reinforces the directional call: underweighting a verifiable fundamental catalyst (here, a guidance raise plus FCF inflection) in favor of technical overbought signals has repeatedly produced wrong directional calls, and a conservative hold stance tends to leave returns on the table.

Net: the fundamental catalyst is real and verifiable, valuation is reasonable, and the yield provides downside support. The main risk is entry timing, which the staged-entry plan addresses. Our analysis assigns a genuine but not extreme edge, reflecting the strong fundamental case offset by the short-term extension and leverage concerns.

What would weaken it

• Short-term technical extension (RSI ~68.9, 16.9% above 200 SMA)
• $70B debt load with $934M/quarter rising interest expense
• Thin liquidity cushion (current ratio 1.16)